NAM
WST icon

NorthCrest Asset Manangement’s West Pharmaceutical WST Stock Holding History

NorthCrest Asset Manangement’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Buy
+690
New +$211K 0.01% 793
2026
Q1 		– Sell
-884
Closed -$247K – 875
2025
Q4 		$247K Buy
884
+109
+14% +$29.8K 0.01% 733
2025
Q3 		$206K Buy
+775
New +$188K ﹤0.01% 717

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NorthCrest Asset Manangement's WST Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in West Pharmaceutical (WST) in Q2 2026: 690 shares worth $247K. The stake represents 0.01% of the portfolio and ranks #793 among its holdings. This is a return to the name: NorthCrest Asset Manangement previously reported a position in WST as recently as Q4 2025.

NorthCrest Asset Manangement first reported a position in WST in Q3 2025 and has held it in 3 quarters since. 121 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • NorthCrest Asset Manangement held 690 shares of West Pharmaceutical worth $247K as of Q2 2026.
  • West Pharmaceutical was a new NorthCrest Asset Manangement position in Q2 2026.
  • West Pharmaceutical made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #793 holding.
  • NorthCrest Asset Manangement first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 121 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.